en Pharmacology Pharmacology گزارش کوتاه Short Communication <p style="text-align: justify;"><span style="font-size:16px;"><span style="font-family:Times New Roman;"><span style="line-height:200%"><span style="line-height:200%">A number of studies have previously provided evidence on the Anti-inflammatory properties of plant-derived compounds that can prevent lung injury. In this study, we attempted to analyze the therapeutic effects of PM 014 on inflammation and pulmonary fibrosis in COVID-19 as well as describing the treatment of one of the most challenging problems related to the coronavirus-19 (COVID-19). We believe that having a close look at all angles of the proposed mechanism goes beyond the physiological consequences of a way to design new strategies for providing an appropriate treatment.</span></span></span></span></p> COVID-19, Anti-inflammatory, Plant-derived, TGF-β, Pulmonary fibrosis 211 214 http://journal.zums.ac.ir/browse.php?a_code=A-10-5253-2&slc_lang=en&sid=1 Maryam Allahverdi-Khani Maryam.Allahverdi@gmail.com 5200319475328460073459 5200319475328460073459 No Clinical Research Development Center, Najafabad Branch, Islamic Azad University, Najafabad, Iran Luis Ulloa luis.ulloa@duke..eu.edu 5200319475328460073460 5200319475328460073460 No Dept. of Anesthesiology, Center for Perioperative Organ Protection, Duke University, Durham, NC, USA Majid Motaghinejad dr.motaghinejad6@gmail.com 5200319475328460073461 5200319475328460073461 Yes Chronic Respiratory Disease Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran Mahsa Salehirad Mahsa.Salehirad@gmail.com 5200319475328460073462 5200319475328460073462 No Cognitive and Neuroscience Research Center (CNRC), Amir-Almomenin Hospital, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran